Abstract Background: Vitiligo is an acquired depigmenting cuta-neous disorder characterized by the loss of melanocytes from the epidermis. It affects approximately 0.5% of the population worldwide. Aim of Study: To determine serum vitamin B 12 level in patients with vitiligo and healthy controls to determine its possible role as a disease biomarker. Patients and Methods: This study was conducted on 40 patients with vitiligo and 40 age and sex matched healthy controls recruited from El-Demerdash Hospital, Ain Shams University. Results: Serum level of vitamin B12 decreased in cases in comparison to control, and there is an inverse relation between vitamin B 12 and affected body parts. Conclusion: This study confirms that vitamin B12 is a very efficient and simple biomarker for vitiligo cases. Thus we recommended the use of vitamin B 12 in investigation to improve our diagnostic capabilities in vitiligo patients.
HANAN M. SALEH. M.D., M. A. E. M., & Y. AHMED, M.D., M. (2021). Serum Level of Vitamin B12 in Patients with Vitiligo and its Potential Role as a Disease Biomarker. The Medical Journal of Cairo University, 89(December), 2953-2958. doi: 10.21608/mjcu.2021.225244
MLA
MAHA A. ELMESELLAWY. M.Sc.; HANAN M. SALEH. M.D.; MARWA Y. AHMED, M.D.. "Serum Level of Vitamin B12 in Patients with Vitiligo and its Potential Role as a Disease Biomarker". The Medical Journal of Cairo University, 89, December, 2021, 2953-2958. doi: 10.21608/mjcu.2021.225244
HARVARD
HANAN M. SALEH. M.D., M. A. E. M., Y. AHMED, M.D., M. (2021). 'Serum Level of Vitamin B12 in Patients with Vitiligo and its Potential Role as a Disease Biomarker', The Medical Journal of Cairo University, 89(December), pp. 2953-2958. doi: 10.21608/mjcu.2021.225244
VANCOUVER
HANAN M. SALEH. M.D., M. A. E. M., Y. AHMED, M.D., M. Serum Level of Vitamin B12 in Patients with Vitiligo and its Potential Role as a Disease Biomarker. The Medical Journal of Cairo University, 2021; 89(December): 2953-2958. doi: 10.21608/mjcu.2021.225244
)
View on SCiNiTO